If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,170.00    30.00 (0.58%)
Bid:
5,160.00
Ask:
5,165.00
Spread: 5.00 (0.097%)
Market Cap: £18.84b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Notice of AGM

19 May 2016 07:30

RNS Number : 6964Y
Coca-Cola HBC AG
19 May 2016
 

 

 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Announcement of the annual general meeting to be held on 21 June 2016

 

Zug, Switzerland - 19 May 2016 - The board of directors of Coca-Cola HBC AG (the "Board of Directors") convenes the Annual General Meeting on 21 June 2016.

The Board of Directors of Coca-Cola HBC AG ("Coca-Cola HBC") has resolved to convene the Annual General Meeting ("AGM") to be held on Tuesday, 21 June 2016 at 11:00am CET, at Hochschule Luzern Wirtschaft Institut für Finanzdienstleistungen Zug IFZ, Grafenauweg 10 (the entrance for guests is at Grafenauweg 8), 6300 Zug, Switzerland.

The Board of Directors proposes to elect Messrs. Ahmet C. Bozer, William W. Douglas III, Reto Francioni and Robert Ryan Rudolph as new members of the Board of Directors, succeeding Messrs. George A. David, Irial Finan, Sir Michael Llewellyn Smith and Nigel Macdonald who will retire from the Board of Directors at the AGM, further details of which were announced separately on 17 May 2016. The Board of Directors believes that Messrs. William W. Douglas III and Reto Francioni qualify as independent under the criteria set forth in the UK Corporate Governance Code. The AGM will also resolve on the proposed dividend of EUR 0.40 per share out of the general capital contribution reserve (capped at an amount of CHF 200,000,000), which was initially announced on 19 February 2016 and further details of which were announced separately on 17 May 2016. In addition, the Board of Directors proposes to reduce the share capital of Coca-Cola HBC by CHF 20,100,000 from CHF 2,466,546,689.90 to CHF 2,446,446,689.90 by cancelling 3,000,000 treasury shares. The AGM agenda items are set out in the summary below.

Agenda of the AGM

In summary, the AGM will have the following agenda and include the following proposals by the Board of Directors.

1. Receipt of the 2015 integrated annual report, as well as approval of the annual management report, the stand-alone financial statements and the consolidated financial statements

2. Appropriation of available earnings and reserves / declaration of dividend

2.1 Appropriation of available earnings

2.2 Declaration of a dividend from reserves

3. Discharge of the members of the Board of Directors and the members of the Operating Committee

 

4. Election of the Board of Directors, the Chairman of the Board of Directors and the Remuneration Committee

4.1 Current members of the Board of Directors

4.1.1 Re-election of Anastassis G. David as a member of the Board of Directors and election as the Chairman of the Board of Directors (in a single vote)

4.1.2 Re-election of Antonio D'Amato as a member of the Board of Directors and as a member of the Remuneration Committee (in a single vote)

4.1.3 Re-election of Alexandra Papalexopoulou as a member of the Board of Directors and as a member of the Remuneration Committee (in a single vote)

4.1.4 Re-election of Olusola (Sola) David-Borha as a member of the Board of Directors

4.1.5 Re-election of Anastasios I. Leventis as a member of the Board of Directors

4.1.6 Re-election of Christodoulos Leventis as a member of the Board of Directors

4.1.7 Re-election of Dimitris Lois as a member of the Board of Directors

4.1.8 Re-election of José Octavio Reyes as a member of the Board of Directors

4.1.9 Re-election of John P. Sechi as a member of the Board of Directors

4.2 New members of the Board of Directors

4.2.1 Election of Ahmet C. Bozer as a member of the Board of Directors

4.2.2 Election of William W. Douglas III as a member of the Board of Directors

4.2.3 Election of Reto Francioni as a member of the Board of Directors and as a member of the Remuneration Committee (in a single vote)

4.2.4 Election of Robert Ryan Rudolph as a member of the Board of Directors

5. Election of the independent proxy

6. Election of the auditors

6.1 Re-election of the statutory auditor

6.2 Advisory vote on re-appointment of the independent registered public accounting firm for UK purposes

 

7. Advisory vote on the UK remuneration report

8. Advisory vote on the Swiss remuneration report

9. Advisory vote on the remuneration policy

10. Approval of the remuneration of the Board of Directors and the Operating Committee

10.1 Approval of the maximum aggregate amount of remuneration for the Board of Directors until the next annual general meeting

10.2 Approval of the maximum aggregate amount of remuneration for the Operating Committee for the next financial year

11. Approval of a share capital reduction by cancelling treasury shares.

The formal notice of the AGM, including a full description of the items of the agenda and the proposals of the Board of Directors, has been published today in the Swiss Official Gazette of Commerce (Schweizerisches Handelsamtsblatt). A circular incorporating the formal notice of the AGM is sent to all registered shareholders. It has also been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morning-star.co.uk/uk/NSM, as well as on Coca-Cola HBC's website at http://coca-colahellenic.com/en/investors/general-meeting/agm-2016/, together with the 2015 integrated annual report and other relevant shareholder information.

Zug, 19 May 2016

Coca-Cola HBC AG

The Board of Directors

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +41 41 726 0143

 basak.kotler@cchellenic.com

 

Nikos Efstathopoulos

Investor Relations Manager

Tel: +30 210 618 3260

 nikos.efstathopoulos@cchellenic.com

Caroline Crampton

Investor Relations Manager

caroline.crampton@cchellenic.com

 

International media contact:

Teneo

Rob Morgan

Ben Ullmann

Anushka Mathew

Tel: +44 20 7240 2486

 robert.morgan@teneostrategy.com

 ben.ullmann@teneostrategy.com

 anushka.mathew@teneostrategy.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with a sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 594 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked beverage industry leader in the Dow Jones Sustainability World and Europe Indices, and is also included in the FTSE4Good Index.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOAEAKSNFANKEEF
Date   Source Headline
2nd Jul 202612:20 pmRNSDirector Declaration
30th Jun 20262:45 pmRNSDirector/PDMR Shareholding
29th Jun 202612:45 pmRNSDirector/PDMR Shareholding
26th Jun 20269:15 amRNSDirector/PDMR Shareholding
26th Jun 20269:15 amRNSDirector/PDMR Shareholding
18th Jun 20263:15 pmRNSDirector/PDMR Shareholding
15th Jun 20265:00 pmRNSDirector/PDMR Shareholding
22nd May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:15 pmRNSDirector/PDMR Shareholding
11th May 20269:00 amRNSDirector Declaration
8th May 20263:15 pmRNSComposition of the Board Committees
8th May 20263:10 pmRNSResult of AGM
7th May 20267:00 amRNSStrong volume drives Q1 sales growth
20th Apr 20263:15 pmRNSDirector/PDMR Shareholding
14th Apr 202612:15 pmRNSNotice of Results
2nd Apr 20267:00 amRNSNotice of AGM, changes to the BoD, dividend dates
1st Apr 20269:15 amRNSTransfer of treasury shares & total voting rights
31st Mar 202611:00 amRNSPublication of Final Terms
27th Mar 20262:45 pmRNSDirector/PDMR Shareholding
27th Mar 20262:15 pmRNSDirector/PDMR Shareholding
26th Mar 20266:18 pmRNSPricing of Issue of Notes
26th Mar 20269:05 amRNSLaunch of Issue of Notes
25th Mar 20261:36 pmRNSPublication of a Prospectus
20th Mar 202611:00 amRNSAnnual Financial Report
19th Mar 20264:55 pmRNSDirector/PDMR Shareholding
19th Mar 20264:45 pmRNSDirector/PDMR Shareholding
18th Mar 20264:15 pmRNSDirector/PDMR Shareholding
18th Mar 202611:35 amRNSDirector/PDMR Shareholding
26th Feb 202611:30 amRNSDirector/PDMR Shareholding
25th Feb 20269:20 amRNSDirector/PDMR Shareholding
24th Feb 20264:55 pmRNSDirector/PDMR Shareholding
24th Feb 20264:50 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:35 pmRNSDirector/PDMR Shareholding
18th Feb 20264:50 pmRNSDirector/PDMR Shareholding
18th Feb 20264:45 pmRNSDirector/PDMR Shareholding
18th Feb 20264:00 pmRNSDirector/PDMR Shareholding
17th Feb 20263:35 pmRNSDirector/PDMR Shareholding
17th Feb 20263:30 pmRNSDirector/PDMR Shareholding
16th Feb 20262:40 pmRNSDirector/PDMR Shareholding
16th Feb 20262:35 pmRNSDirector/PDMR Shareholding
13th Feb 202610:30 amRNSDirector/PDMR Shareholding
12th Feb 20263:45 pmRNSDirector/PDMR Shareholding
12th Feb 20261:15 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSStrong execution and financial performance in 2025
2nd Feb 202610:00 amRNSTransfer of treasury shares & total voting rights
19th Jan 20264:00 pmRNSDirector/PDMR Shareholding
19th Jan 20262:20 pmRNSResult of Extraordinary General Meeting
13th Jan 202611:00 amRNSNotice of Results
5th Jan 202610:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.